"Hepatitis C, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Descriptor ID |
D019698
|
| MeSH Number(s) |
C02.440.440.120 C02.782.350.350.120 C06.552.380.350.120 C06.552.380.705.440.120
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C, Chronic".
This graph shows the total number of publications written about "Hepatitis C, Chronic" by people in this website by year, and whether "Hepatitis C, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 0 | 3 |
| 2001 | 5 | 0 | 5 |
| 2002 | 2 | 2 | 4 |
| 2003 | 5 | 0 | 5 |
| 2004 | 2 | 1 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 2 | 4 |
| 2007 | 6 | 0 | 6 |
| 2008 | 4 | 0 | 4 |
| 2009 | 4 | 4 | 8 |
| 2010 | 12 | 3 | 15 |
| 2011 | 8 | 0 | 8 |
| 2012 | 9 | 1 | 10 |
| 2013 | 15 | 0 | 15 |
| 2014 | 13 | 0 | 13 |
| 2015 | 14 | 0 | 14 |
| 2016 | 14 | 0 | 14 |
| 2017 | 15 | 1 | 16 |
| 2018 | 10 | 2 | 12 |
| 2019 | 13 | 2 | 15 |
| 2020 | 4 | 0 | 4 |
| 2021 | 7 | 0 | 7 |
| 2022 | 11 | 0 | 11 |
| 2023 | 6 | 0 | 6 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis C, Chronic" by people in Profiles.
-
Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. J Natl Compr Canc Netw. 2024 05 10; 22(2 D).
-
Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2024 Jun; 78(6):1342-1354.
-
Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology. 2025 Jan 01; 81(1):358-379.
-
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline. Ann Intern Med. 2023 12; 176(12):1648-1655.
-
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2024 01; 22(1):72-80.e4.
-
Progression of fibrosis in liver transplant recipients with hepatitis C before and after sustained virologic response. Clin Transplant. 2023 10; 37(10):e15050.
-
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors. Am J Gastroenterol. 2023 09 01; 118(9):1609-1617.
-
Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals. Clin Gastroenterol Hepatol. 2024 01; 22(1):91-101.e6.
-
Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. Clin Infect Dis. 2023 02 18; 76(4):592-599.
-
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance. Ann Hepatol. 2023 Mar-Apr; 28(2):100899.